Peter Beitsch, MD | Authors


Dr. Peter Beitsch on the Benefits of Grouping Patients With Breast Cancer by Subtype for Trials

February 16, 2016

Beitsch says that while having a study that incorporates several thousands of patients will potentially produce statistically significant results, these larger groups may not account for subtypes in each patient's individual cancer.